Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC. - Wikidata - wikimedia - TriplyDB

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

http://www.wikidata.org/entity/Q37576985

about

Hepatocellular carcinoma and the risk of occupational exposure Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies Current status and perspectives of immune-based therapies for hepatocellular carcinoma Systematic review: the effects of autologous stem cell therapy for patients with liver disease Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies Immunotherapy for hepatocellular carcinoma: From basic research to clinical use.The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors.Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma Comparative investigation of the effects of specific antigen‑sensitized DC‑CIK and DC‑CTL cells against B16 melanoma tumor cells.Systemic therapies in hepatocellular carcinoma: present and future.Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.Developments in cancer vaccines for hepatocellular carcinoma.Immunological landscape and immunotherapy of hepatocellular carcinoma.Cellular immunotherapy of cancer: an overview and future directions.Specific immunotherapy in hepatocellular cancer: A systematic review.Promising new strategies for hepatocellular carcinoma.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Current immunotherapeutic strategies in hepatocellular carcinoma: recent advances and future directions.Cancer vaccines for hepatocellular carcinoma: future directions.Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells.Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma.The effects of hemocyanin on T cells cultured in vitro.Immunotherapy in Gastrointestinal Cancers.What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO).Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).Immunotherapy of hepatocellular carcinoma Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma

P2860

Q26750646-8461577E-A6AA-4839-9EDE-0C814223B86B Q26752558-7B9DE9D2-9ED9-41D3-BF87-987C65AEA51A Q26772326-F6FF53D1-32BF-42F0-BCA3-183B0089E2A0 Q27024968-544B097E-EEBD-4774-A310-A9A00662816B Q33895113-8129C32F-CD7F-4F3A-BE9F-F8651A7407B1 Q35567765-20A8B553-24F0-443A-8CB3-A0144271EF52 Q36270334-A18B9AF3-E677-435A-BE5A-97A2190ABCD9 Q36571270-D8B38B6A-DF4C-4989-9C5D-75B9D52C027D Q37720231-74DEAC3C-103E-4FEB-A2C8-E5C15BC0739D Q38150875-576078E8-2B81-4040-A48D-6B1E05064921 Q38177324-2BB24DFD-AA63-45E9-8104-B171F410E50C Q38533017-037DA4F9-EFFE-4AB1-9BC9-D741C17C12C6 Q38611895-65212EF5-5111-4F11-846A-A89FAFB684CF Q38673161-F820610C-7B2E-4B18-B782-79576EFA6461 Q38840178-F3D627BE-7197-441D-A87D-257DFA20ADC1 Q38936589-04F17F23-0234-4F88-9ACA-043435546E0F Q39535683-5143470E-FA96-4DA0-ACCC-E6ABE114F67F Q42375643-FEE6B374-1F52-4121-A37A-57B6CA462553 Q44211246-8667C7B9-8095-4292-B5F0-201D392B312E Q47160856-3A2164F3-5FB0-4FA3-98D0-526329A91C30 Q47552123-E9226F76-6941-4545-B2F6-762DFDF25D5C Q49168467-D7F881AF-2108-40CC-9154-7E2260AA7800 Q50053424-FBEC7447-A78F-467E-822C-530DA5CFF66D Q53183990-15F5F945-DBA3-4099-8283-E92E36B7EB20 Q54839137-7F4B5A80-5413-4CBA-9A73-1AA3133D83F6 Q54963955-5F392CB8-F4A4-4026-A0B2-5E0D657703B7 Q55008075-0087397C-13AE-4AD6-874F-BDD1AF7F1C1D Q55709201-1B9B1F27-D091-4838-BF55-B21E2C48F016 Q56896669-710295D3-53DA-4C8C-91F0-1D214726EE1A Q59135320-B5D23C41-826C-4406-9190-5D89B5D7E2C1

P2860

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

http://www.wikidata.org/entity/Q37576985

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 August 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

@en

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

@nl

type

label

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

@en

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

@nl

prefLabel

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

@en

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

@nl

P1433

Q37576985-2413DDB6-7CA2-45D0-B581-113F2546868F

P1476

Q37576985-0B9664D7-9B22-4CEA-BE0E-6FB2AC3242FC

P2093

Q37576985-17550CC0-177E-4DDA-BA8D-1BCB6593C39A

Q37576985-525DDB1C-8843-4089-8AAF-85B0879E5350

Q37576985-570FAA8E-A7C1-4331-BFA8-53CAD40E4DDC

Q37576985-8DB1DDB1-D2E1-4190-924F-7BAA9B9DC262

Q37576985-8F93679A-CA4E-4747-A48B-E90EB8C59F8B

Q37576985-BE58F1D8-2CD0-4DCE-80CA-1EB20F128F2D

P2860

Q37576985-0CE9D7BC-06C8-45AA-8FF7-C691149668BA

Q37576985-260C34C8-2DCD-40C9-B30F-51500126870A

Q37576985-368C8048-7D1E-4494-8D26-685BE8CF2D6B

Q37576985-3B931890-60FE-4550-9829-ED3DE902191D

Q37576985-42A4EBA1-E7E2-43AF-8444-203A518E3722

Q37576985-4A569E34-4013-4D1F-A6E3-D423C1D937DB

Q37576985-728A4D44-4D93-49B7-A2A3-AE5080F625EC

Q37576985-863C2265-C9C2-445F-99D2-466845DC500E

Q37576985-8FEDE814-FE71-4B59-B9F9-AE7102AA19EE

Q37576985-9C6AD294-18E0-44E0-A92B-3AFF524A4BB4

P2888

Q37576985-919CE880-DBCC-4F1E-98BE-80197C4A0D8C

P304

Q37576985-5F6388AE-92A0-470B-92D5-F7499F118B47

P31

Q37576985-3A1A1802-7430-42E9-A55D-FD561688386B

P356

Q37576985-9A4EAEB2-62E3-4628-AFF8-49229517C99A

P433

Q37576985-5AF719FC-0491-447D-9E55-430C9E569CE0

P478

Q37576985-1424A95E-9B03-4719-991D-D40352A66570

P50

Q37576985-B2619894-0779-4260-8225-245F60B03D41

P577

Q37576985-AFC6F09B-31FD-4184-8C20-F42A295F1669

P698

Q37576985-DB83DBB7-4CF3-4FF6-A5D4-0ADD33178403

P921

Q37576985-0E200240-8EAA-46F9-9D55-14BD864AFAF5

Q37576985-71704439-1CC0-4688-976B-FAD4C6B642AD

P932

Q37576985-DFA8F379-95CE-4374-9820-56A38B40BBD3

P356

S00432-012-1298-8

P1433

Journal of Cancer Research and Clinical Oncology

P1476

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC

@en

P2093

Fatma Aboelkasem

http://www.w3.org/2001/XMLSchema#string

Hatem El Sabaawy

http://www.w3.org/2001/XMLSchema#string

Mervat El Ansary

http://www.w3.org/2001/XMLSchema#string

Olfat Abdelhalim

http://www.w3.org/2001/XMLSchema#string

Sahr Alwakil

http://www.w3.org/2001/XMLSchema#string

Samah Abd Elhamid

http://www.w3.org/2001/XMLSchema#string

P2860

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.

CD83 on dendritic cells: more than just a marker for maturation.

Estimating the world cancer burden: Globocan 2000.

Gene- and immunotherapy for hepatocellular carcinoma.

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Strategies for the management of hepatocellular carcinoma.

Dendritic Cells-based Vaccine and Immune Monitoring for Hepatocellular Carcinoma.

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.

Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.

P2888

s00432-012-1298-8

P304

39-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-012-1298-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22886490

http://www.w3.org/2001/XMLSchema#string

P921

P932

5223882

http://www.w3.org/2001/XMLSchema#string